Guidelines for the initiation of obesity treatment

Journal of Nutritional Biochemistry

Volumn 9, Issue 10, 1998, Pages 546-552

  Atkinson, Richard L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Behavioral therapy; body mass index; Co morbidities; Diet; Exercise; Medications; Obesity surgery; Risk factors

Indexed keywords

ACARBOSE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEPRAMONE; AMPHETAMINE; BENZPHETAMINE; CAFFEINE; EPHEDRINE; FENFLURAMINE; FLUOXETINE; MAZINDOL; METHAMPHETAMINE; PHENMETRAZINE; PHENTERMINE; PHENYLPROPANOLAMINE; SEROTONIN AGONIST; SERTRALINE; TETRAHYDROLIPSTATIN;

BEHAVIOR THERAPY; BODY MASS; DIET; EXERCISE; HUMAN; OBESITY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; WEIGHT REDUCTION;

EID: 0032189570     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(98)00033-3     Document Type: Review

References (29)

1. Kuczmarski R.J., Flegal K.M., Campbell S.M., Johnson C.L. Increasing prevalence of overweight among U.S. adults. JAMA. 272:1994;205-211.
2. McGinnis J.M., Foege W.H. Actual causes of death in the United States. JAMA. 270:1993;2207-2212.
3. Thomas P.R. Weighing the Options. Criteria for Evaluating Weight-Management Programs. 1995;National Academy Press, Washington, DC, USA.
4. Weintraub M., et al. Long-term weight control The National Heart, Lung, and Blood Institute funded multimodal intervention study . Clin. Pharmacol. Ther. 51:1992;581-646.
5. Standards of Bariatric Practice. (1997) American Society of Bariatric Physicians, Englewood, CO, USA.
6. Pi-Sunyer X. Guidelines for the approval and use of obesity drugs. Obes. Res. 3:1995;473-478.
7. Guidance for Treatment of Adult Obesity. (1996). Shape Up America! and American Obesity Association, Shape Up America!, Bethesda, MD, USA.
8. New weight standards for men and women. Stat. Bull. Metropol. Life Insur. Co. 40:1959;1-4.
9. Najjar, M.F. and Rowland M. (1987). Anthropometric reference data and prevalence of overweight, United States, 1976-80. Vital Health Stat. 11, 238.
10. Foster W.R., Burton B.T. Health Implications of Obesity, National Institutes of Health Consensus Development Conference. Ann. Intern. Med. 103:(6 pt 2):1985;981-1077.
11. Report of the Task Force on the Treatment of Obesity. (1991). Health Services and Promotion Branch, Health and Welfare Canada.
12. World Health Organization. (1998). Preventing and managing the global epidemic of obesity: report of a WHO Consultation on Obesity. Geneva, 3-5 June 1997. WHO/NUT/NCD98.1, Geneva, Switzerland.
13. Brownell K.D. The Learn Program for Weight Control. 1991;American Health Publishing Co, Dallas, TX, USA.
14. Boozer C.N., Schoenbach G., Atkinson R.L. Dietary fat and adiposity a dose-response relationship in adult rats fed isocalorically . Am. J. Physiol. 268:1995;E546-E550.
15. Life Sciences Research Office. (1987). Physiological Effects and Health Consequences of Dietary Fiber (S.M. Pilch, ed.), p. 160, Federation of American Societies for Experimental Biology, Contract Number FDA 223-84-2059, Washington, DC, USA.
16. Atkinson R.L., Kaiser D.L. Effects of calorie restriction and weight loss on glucose and insulin levels in obese humans. J. Am. Coll. Nutr. 4:1985;411-419.
17. Wing R.R., Marcus M.D., Salata R., Epstein L.H., Miaskiewicz S., Blair E.H. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetics subjects. Arch. Intern. Med. 151:1991;1334-1340.
18. Zurlo F., Ferraro R.T., Fontvieille A.M., Rising R., Bogardus C., Ravussin E. Spontaneous physical activity and obesity cross-sectional and longitudinal studies in Pima Indians . Am. J. Physiol. 263:1992;E296-E300.
19. Long-term pharmacotherapy in the management of obesity. JAMA. 276:1996;1907-1915.
20. Abenhaim L., Moride Y., Brenot F., et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N. Engl. J. Med. 335:1996;609-616.
21. Connolly H.M., Crary J.L., McGoon M.D., Hensrud D.D., Edwards B.S., Edwards W.D., Schaff H.V. Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337:1997;581-588.
22. Bray G.A., Ryan D.H., Gordon D., Heidingsfelder S., Cerise F., Wilson K. A double-blind randomized placebo-controlled trial of sibutramine. Obes. Res. 4:1996;263-270.
23. Lean M.E.J. Sibutramine - a review of clinical efficacy. Int. J. Obes. 21:1997;S30-S36.
24. James W.P., Avenell A., Broom J., Whitehead J. A one-year trial to assess the value of orlistat in the management of obesity. Int. J. Obes. 21:(suppl 3):1997;S24-S30.
25. Pories W.J., Swanson M.S., MacDonald K.G., Long S.B., Morris P.G., Brown B.M., Barakat H.A., deRamon R.A., Israel G., Dolezal J.M., Dohm L. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann. Surg. 222:1995;339-352.
26. MacDonald K.G., Long S.D., Swanson M.S., Brown B.M., Morris P., Dohm G.L., Pories W.J. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J. Gastrointest. Surg. 1:1997;213-220.
27. Sugerman H.J., Londrey G.L., Kellum J.M., Wolf L., Liszka T., Engle K.M., Birkenhauer R., Starkey J.V. Weight loss with vertical banded gastroplasty and roux-y gastric bypass for morbid obesity with selective versus random assignment. Am. J. Surg. 157:1989;93-102.
28. Kral J.G. Surgical treatment of obesity. Bray G.A., Bouchard C., James W.P.T. Handbook of Obesity. 1997;977-993 Marcel Dekker, New York, NY, USA.
29. Atkinson R.L. Proposed standards for judging success of the treatment of obesity. Ann. Intern. Med. 119:1993;677-680.